{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:36:16Z","timestamp":1791462976736,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T00:00:00Z","timestamp":1728691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Salivary hypofunction leads to debilitating oral symptoms and has major complications for overall quality of life. Two of the most frequent causes of xerostomia are radiotherapy in the head and neck and Sj\u00f6gren\u2019s syndrome. Only symptomatic treatment is available today. An increasing number of both preclinical and clinical studies have suggested that mesenchymal stem cell (MSC) transplantation treatment can increase the salivary flow rate and ameliorate symptoms of xerostomia. However, both adipose-derived and bone marrow\u2013derived MSCs are used, although they differ in important ways. The primary objective of this study is an indirect comparison of the change in the unstimulated salivary flow rate after intervention between patients treated with adipose-derived or bone marrow\u2013derived MSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This systematic review and network meta-analysis will search for eligible studies in the MEDLINE, EMBASE, and Cochrane CENTRAL register of Controlled Trials. Eligible studies are as follows: clinical studies including human patients with salivary hypofunction due to either radiotherapy or Sjogren\u2019s syndrome who were subsequently treated with either adipose-derived MSCs or bone marrow\u2013derived MSCs. Studies with no control group will be excluded. The search phrase has been peer-reviewed following the PRESS guidelines. The primary outcome is the change in the unstimulated salivary flow rate after treatment with either adipose-derived or bone marrow\u2013derived MSCs. Secondary outcomes are as follows: change in patient reported outcomes, methods of intervention administration, number of injected MSCs, and safety. Data from included studies will be pooled and compared with a fixed-effects or random effects model dependent on signs of heterogeneity, presented with a forest plot, and indirectly compared with a meta-regression in a network meta-analysis. Risk of bias will be assessed with the tools ROBINS-I or RoB-2 depending on type of study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Both adipose-derived and bone marrow\u2013derived MSCs are used today for experimental treatment of salivary hypofunction in humans as no direct or indirect comparisons have been made. Therefore, an evaluation of the effect of adipose-derived vs bone marrow\u2013derived MSC treatment is needed to support future decision-making on the type of MSC used in a clinical trial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO ID CRD42024527183.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-024-02674-2","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T11:01:51Z","timestamp":1728730911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Adipose derived or bone-marrow derived mesenchymal stem cell treatment for hyposalivation: protocol for a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-5037","authenticated-orcid":false,"given":"Joachim","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda-Louise Fenger","family":"Carlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine Kronberg","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,12]]},"reference":[{"key":"2674_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/02841869409083923","volume":"33","author":"AB Jensen","year":"1994","unstructured":"Jensen AB, Hansen O, J\u00f8rgensen K, Bastholt L. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol. 1994;33:487\u201391. https:\/\/doi.org\/10.3109\/02841869409083923.","journal-title":"Acta Oncol"},{"key":"2674_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/S10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22:9. https:\/\/doi.org\/10.1007\/S10238-021-00728-6.","journal-title":"Clin Exp Med"},{"key":"2674_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3109\/00016357.2015.1099730","volume":"74","author":"P Lopez-Jornet","year":"2016","unstructured":"Lopez-Jornet P, Lucero Berdugo M, Fernandez-Pujante A, Castillo FC, Zamora LC, Pons-Fuster A, et al. Sleep quality in patients with xerostomia: a prospective and randomized case-control study. Acta Odontol Scand. 2016;74:224\u20138. https:\/\/doi.org\/10.3109\/00016357.2015.1099730.","journal-title":"Acta Odontol Scand"},{"key":"2674_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/J.EJCA.2017.03.006","volume":"78","author":"S H\u00f8xbroe Michaelsen","year":"2017","unstructured":"H\u00f8xbroe Michaelsen S, Gr\u00f8nh\u00f8j C, H\u00f8xbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: a systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91\u2013102. https:\/\/doi.org\/10.1016\/J.EJCA.2017.03.006.","journal-title":"Eur J Cancer"},{"key":"2674_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.oooo.2013.11.496","volume":"117","author":"DH Jensen","year":"2014","unstructured":"Jensen DH, Oliveri RS, Trojahn K\u00f8lle S-F, Fischer-Nielsen A, Specht L, Bardow A, et al. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:335-342.e1. https:\/\/doi.org\/10.1016\/j.oooo.2013.11.496.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2674_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.17219\/ACEM\/29375","volume":"25","author":"M Tanasiewicz","year":"2016","unstructured":"Tanasiewicz M, Hildebrandt T, Obersztyn I. Xerostomia of various etiologies: a review of the literature. Adv Clin Exp Med. 2016;25:199\u2013206. https:\/\/doi.org\/10.17219\/ACEM\/29375.","journal-title":"Adv Clin Exp Med"},{"key":"2674_CR7","doi-asserted-by":"publisher","unstructured":"Chihaby N, Orliaguet M, Le Pottier L, Pers JO, Boisram\u00e9 S. Treatment of Sj\u00f6gren\u2019s syndrome with mesenchymal stem cells: a systematic review. Int J Mol Sci 2021;22. https:\/\/doi.org\/10.3390\/IJMS221910474.","DOI":"10.3390\/IJMS221910474"},{"key":"2674_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/J.JCYT.2023.07.009","volume":"25","author":"GC Blitzer","year":"2023","unstructured":"Blitzer GC, Glazer T, Burr A, Gustafson S, Ganz O, Meyers R, et al. Marrow-derived autologous stromal cells for the restoration of salivary hypofunction (MARSH): a pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia. Cytotherapy. 2023;25:1139\u201344. https:\/\/doi.org\/10.1016\/J.JCYT.2023.07.009.","journal-title":"Cytotherapy"},{"key":"2674_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/J.IJROBP.2018.02.034","volume":"101","author":"C Gr\u00f8nh\u00f8j","year":"2018","unstructured":"Gr\u00f8nh\u00f8j C, Jensen DH, Vester-Glowinski P, Jensen SB, Bardow A, Oliveri RS, et al. Safety and efficacy of mesenchymal stem cells for radiation-induced xerostomia: a randomized, placebo-controlled phase 1\/2 trial (MESRIX). Int J Radiat Oncol Biol Phys. 2018;101:581\u201392. https:\/\/doi.org\/10.1016\/J.IJROBP.2018.02.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2674_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/STCLTM\/SZAC011","volume":"11","author":"CD Lynggaard","year":"2022","unstructured":"Lynggaard CD, Gr\u00f8nh\u00f8j C, Christensen R, Fischer-Nielsen A, Melchiors J, Specht L, et al. Intraglandular off-the-shelf allogeneic mesenchymal stem cell treatment in patients with radiation-induced xerostomia: a safety study (MESRIX-II). Stem Cells Transl Med. 2022;11:478. https:\/\/doi.org\/10.1093\/STCLTM\/SZAC011.","journal-title":"Stem Cells Transl Med"},{"key":"2674_CR11","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1182\/BLOOD-2011-11-391144","volume":"120","author":"J Xu","year":"2012","unstructured":"Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood. 2012;120:3142\u201351. https:\/\/doi.org\/10.1182\/BLOOD-2011-11-391144.","journal-title":"Blood"},{"key":"2674_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jcyt.2018.01.009","volume":"20","author":"K Le Blanc","year":"2018","unstructured":"Le Blanc K, Davies LC. MSCs\u2014cells with many sides. Cytotherapy. 2018;20:273\u20138. https:\/\/doi.org\/10.1016\/j.jcyt.2018.01.009.","journal-title":"Cytotherapy"},{"key":"2674_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143\u20137.","journal-title":"Science"},{"key":"2674_CR14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/S13063-023-07594-5","volume":"24","author":"KK Jakobsen","year":"2023","unstructured":"Jakobsen KK, Carlander ALF, Gr\u00f8nh\u00f8j C, Todsen T, Melchiors J, Paaske N, et al. Effectiveness and safety of mesenchymal stem\/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study. Trials. 2023;24:567. https:\/\/doi.org\/10.1186\/S13063-023-07594-5.","journal-title":"Trials"},{"key":"2674_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/S12015-023-10641-Y","volume":"20","author":"Y Cao","year":"2024","unstructured":"Cao Y, Yan J, Dong Z, Wang J, Jiang X, Cui T, et al. Adipose-derived mesenchymal stem cells are ideal for the cell-based treatment of refractory wounds: strong potential for angiogenesis. Stem Cell Rev Rep. 2024;20:313\u201328. https:\/\/doi.org\/10.1007\/S12015-023-10641-Y.","journal-title":"Stem Cell Rev Rep"},{"key":"2674_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/IJMS242316920\/S1","volume":"24","author":"M Yoshida","year":"2023","unstructured":"Yoshida M, Nakashima A, Ishiuchi N, Miyasako K, Morimoto K, Tanaka Y, et al. Comparison of the therapeutic effects of adipose- and bone marrow-derived mesenchymal stem cells on renal fibrosis. Int J Mol Sci. 2023;24:24. https:\/\/doi.org\/10.3390\/IJMS242316920\/S1.","journal-title":"Int J Mol Sci"},{"key":"2674_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13287-018-0914-1\/FIGURES\/6","volume":"9","author":"S Mohamed-Ahmed","year":"2018","unstructured":"Mohamed-Ahmed S, Fristad I, Lie SA, Suliman S, Mustafa K, Vindenes H, et al. Adipose-derived and bone marrow mesenchymal stem cells: a donor-matched comparison. Stem Cell Res Ther. 2018;9:1\u201315. https:\/\/doi.org\/10.1186\/S13287-018-0914-1\/FIGURES\/6.","journal-title":"Stem Cell Res Ther"},{"key":"2674_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","volume":"75","author":"J McGowan","year":"2016","unstructured":"McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40\u20136. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.01.021.","journal-title":"J Clin Epidemiol"},{"key":"2674_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1136\/BMJ.G7647","volume":"2015","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P), et al. elaboration and explanation. BMJ. 2015;2015:349. https:\/\/doi.org\/10.1136\/BMJ.G7647.","journal-title":"BMJ"},{"key":"2674_CR20","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355. https:\/\/doi.org\/10.1136\/BMJ.I4919.","DOI":"10.1136\/BMJ.I4919"},{"key":"2674_CR21","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366. https:\/\/doi.org\/10.1136\/BMJ.L4898.","DOI":"10.1136\/BMJ.L4898"},{"key":"2674_CR22","unstructured":"Risk of bias tools n.d. https:\/\/sites.google.com\/site\/riskofbiastool\/welcome. Accessed 9\u00a0Sept 2024."},{"key":"2674_CR23","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions | Cochrane Training n.d. https:\/\/training.cochrane.org\/handbook\/current. Accessed\u00a0 11\u00a0Mar 2024."},{"key":"2674_CR24","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/CMAJ.200077\/-\/DC1","volume":"192","author":"S Schandelmaier","year":"2020","unstructured":"Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasenapathy N, Hayward RA, et al. Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses. CMAJ. 2020;192:E901\u20136. https:\/\/doi.org\/10.1503\/CMAJ.200077\/-\/DC1.","journal-title":"CMAJ"},{"key":"2674_CR25","doi-asserted-by":"publisher","unstructured":"Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 2020;368. https:\/\/doi.org\/10.1136\/BMJ.L6890.","DOI":"10.1136\/BMJ.L6890"},{"key":"2674_CR26","doi-asserted-by":"publisher","unstructured":"Gr\u00f8nh\u00f8j C, Jensen D, Mafioso R, Fischer-Nielsen A, Specht L, Fog Munthe L, et al. Safety and efficacy of autologous tissue-derived mesenchymal stem cells for radiation- induced xerostomia: a randomized, placebo-controlled phase I\/II trial (MESRIX). Int J Radiat Oncol Biol Phys. 2018;101(3):581\u201392. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.034.","DOI":"10.1016\/j.ijrobp.2018.02.034"},{"key":"2674_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/J.1601-0825.2010.01723.X","volume":"17","author":"RP Coppes","year":"2011","unstructured":"Coppes RP, Stokman MA. Stem cells and the repair of radiation-induced salivary gland damage. Oral Dis. 2011;17:143\u201353. https:\/\/doi.org\/10.1111\/J.1601-0825.2010.01723.X.","journal-title":"Oral Dis"},{"key":"2674_CR28","doi-asserted-by":"publisher","unstructured":"Jansson PM, Lynggaard CD, Carlander AF, Jensen SB, Follin B, Hoeeg C, et al. Mesenchymal stromal\/stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a systematic review and meta-analysis. Syst Rev 2022;11. https:\/\/doi.org\/10.1186\/S13643-022-01943-2.","DOI":"10.1186\/S13643-022-01943-2"},{"key":"2674_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2217\/rme-2017-0152","volume":"13","author":"Y Song","year":"2018","unstructured":"Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, et al. Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections. Regenerative Med. 2018;13:295\u2013307. https:\/\/doi.org\/10.2217\/rme-2017-0152.","journal-title":"Regenerative Med"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02674-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T15:13:31Z","timestamp":1729005211000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02674-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,12]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2674"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02674-2","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,12]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}